JP2021505527A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505527A5 JP2021505527A5 JP2020521460A JP2020521460A JP2021505527A5 JP 2021505527 A5 JP2021505527 A5 JP 2021505527A5 JP 2020521460 A JP2020521460 A JP 2020521460A JP 2020521460 A JP2020521460 A JP 2020521460A JP 2021505527 A5 JP2021505527 A5 JP 2021505527A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- omega
- zeaxanthin
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1720119.5A GB201720119D0 (en) | 2017-12-04 | 2017-12-04 | Prevention and/or treatment of neurodegenerative disease |
| GB1720119.5 | 2017-12-04 | ||
| PCT/GB2018/051255 WO2019110951A1 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021505527A JP2021505527A (ja) | 2021-02-18 |
| JP2021505527A5 true JP2021505527A5 (enExample) | 2021-07-26 |
Family
ID=60950313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020521460A Pending JP2021505527A (ja) | 2017-12-04 | 2018-05-10 | 神経変性疾患の予防及び／又は治療 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10835509B2 (enExample) |
| EP (2) | EP4599891A3 (enExample) |
| JP (1) | JP2021505527A (enExample) |
| KR (1) | KR20200095452A (enExample) |
| AU (1) | AU2018379644B2 (enExample) |
| BR (1) | BR112020005132A2 (enExample) |
| CA (1) | CA3071786C (enExample) |
| ES (1) | ES3047101T3 (enExample) |
| GB (2) | GB201720119D0 (enExample) |
| IE (1) | IE87241B1 (enExample) |
| MX (1) | MX2020002458A (enExample) |
| RU (1) | RU2020111305A (enExample) |
| SG (1) | SG11202000786RA (enExample) |
| WO (1) | WO2019110951A1 (enExample) |
| ZA (1) | ZA202000558B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3106957B1 (fr) * | 2020-02-07 | 2024-05-03 | Abdelhadi Zahouani | Composition alimentaire pour stimuler la fonction cognitive et prevenir et limiter le declin cognitif et la demence chez des sujets adultes ou chez des sujets ages denutris |
| US12076299B2 (en) * | 2020-02-20 | 2024-09-03 | Arjuna Natural Pvt Ltd | Composition and method to enhance cognitive support and brain health |
| KR20240008846A (ko) * | 2021-05-17 | 2024-01-19 | 오노 야꾸힝 고교 가부시키가이샤 | 인지 기능을 개선하기 위한 조성물 |
| JPWO2024143060A1 (enExample) * | 2022-12-26 | 2024-07-04 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006121421A2 (en) | 2004-01-14 | 2006-11-16 | Robert Ritch | Methods and formulations for treating glaucoma |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| WO2006116755A2 (en) * | 2005-04-28 | 2006-11-02 | Trustees Of Tufts College | Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function |
| WO2009078716A1 (en) * | 2007-12-17 | 2009-06-25 | Newtricious B.V. | Method of producing egg yolk based functional food product and products obtainable thereby |
| GB201014340D0 (en) | 2010-08-27 | 2010-10-13 | Piraee Mahmood | Nutritional supplement formulation comprising saffron and resveratrol |
| JP2014524914A (ja) * | 2011-07-07 | 2014-09-25 | ハワード・ファウンデーション・ホールディングス・リミテッド | 視覚パフォーマンス及び／若しくは黄斑色素形成の改善、又は視覚パフォーマンス及び／若しくは黄斑色素形成に関連した改善 |
| KR101660195B1 (ko) * | 2012-07-19 | 2016-09-26 | 유.에스. 뉴트라수티칼스, 엘.엘.씨. | 크릴 오일과 반응한 아스타잔틴 조성물 및 관련 방법 |
| US20140187648A1 (en) * | 2013-01-03 | 2014-07-03 | Howard Foundation Holdings Ltd. | Identifying Subjects in Need of Treatment |
| GB201300055D0 (en) * | 2013-01-03 | 2013-02-20 | Howard Foundation Holdings Ltd | Identifying subjects in need of treatment |
| CN105120853A (zh) * | 2013-03-28 | 2015-12-02 | 奥米尼埃克蒂夫健康科技有限公司 | 类胡萝卜素的脑内神经保护作用 |
| US9480672B2 (en) * | 2013-07-10 | 2016-11-01 | Lion Corporation | Internal composition |
| JP6719574B2 (ja) * | 2016-02-22 | 2020-07-08 | ニュートリシャス ベー．フェー．Ｎｅｗｔｒｉｃｉｏｕｓ Ｂ．Ｖ． | 神経変性疾患の、予防または治療のための組成物 |
-
2017
- 2017-12-04 GB GBGB1720119.5A patent/GB201720119D0/en not_active Ceased
-
2018
- 2018-05-10 RU RU2020111305A patent/RU2020111305A/ru unknown
- 2018-05-10 KR KR1020207007980A patent/KR20200095452A/ko active Pending
- 2018-05-10 WO PCT/GB2018/051255 patent/WO2019110951A1/en not_active Ceased
- 2018-05-10 CA CA3071786A patent/CA3071786C/en active Active
- 2018-05-10 EP EP25186112.6A patent/EP4599891A3/en active Pending
- 2018-05-10 JP JP2020521460A patent/JP2021505527A/ja active Pending
- 2018-05-10 BR BR112020005132-2A patent/BR112020005132A2/pt not_active Application Discontinuation
- 2018-05-10 GB GB1807590.3A patent/GB2568986B/en active Active
- 2018-05-10 MX MX2020002458A patent/MX2020002458A/es unknown
- 2018-05-10 AU AU2018379644A patent/AU2018379644B2/en active Active
- 2018-05-10 SG SG11202000786RA patent/SG11202000786RA/en unknown
- 2018-05-10 EP EP18725605.2A patent/EP3644979B1/en active Active
- 2018-05-10 ES ES18725605T patent/ES3047101T3/es active Active
- 2018-05-15 US US15/980,083 patent/US10835509B2/en active Active
- 2018-05-15 IE IE20180146A patent/IE87241B1/en unknown
-
2020
- 2020-01-28 ZA ZA2020/00558A patent/ZA202000558B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2826201T3 (es) | Cápsulas entéricas blandas que comprenden ácidos grasos poliinsaturados | |
| JP2021505527A5 (enExample) | ||
| CN105120872B (zh) | 包含15-hepe的组合物以及其使用方法 | |
| JP2023153863A (ja) | １５－ｈｅｐｅを含む組成物及びその使用方法 | |
| US20130108706A1 (en) | Dietary formulations | |
| CN102843922A (zh) | 硝基脂肪酸–认知减退的神经保护和/或抑制 | |
| JP2016053065A5 (enExample) | ||
| CN103533921A (zh) | 用于治疗神经外伤的方法 | |
| RU2020111305A (ru) | Предупреждение и/или лечение нейродегенеративного заболевания | |
| JP2020090508A5 (enExample) | ||
| RU2020101477A (ru) | Фармацевтические композиции, содержащие дглк, и их применение | |
| DK2768316T3 (en) | LIPID COMPOSITION FOR PREVENTION OR TREATMENT OF SKIN PROBLEMS | |
| ES2332102T3 (es) | Composicion que contiene acidos grasos omega 3 y acidos grasos omega 6. | |
| CN108882722A (zh) | 食用油中的按时释放维生素和矿物质 | |
| NZ761512B2 (en) | Prevention and/or treatment of neurodegenerative disease | |
| KR20050010464A (ko) | 치료제 | |
| Crawford | Another Supplement for CAD Prevention Fails | |
| JP6912214B2 (ja) | 赤血球機能向上剤 | |
| GB2504061A (en) | Omega-6 Enriched PUFA Phospholipids | |
| JP3249657U (ja) | フィッシュオイル配合物を含むソフトカプセル構造 | |
| JP2015145421A (ja) | 体重減少および肥満処置の方法 | |
| JP2017536367A5 (enExample) | ||
| JP2014122210A (ja) | ビタミンｂ１誘導体組成物 | |
| JPWO2020049549A5 (enExample) | ||
| IT201700116392A1 (it) | Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa |